Computerized System Provides High-Fidelity Heart Rhythm Data
By HospiMedica International staff writers Posted on 27 Aug 2018 |
Image: The PURE EP System (Photo courtesy of BioSig Technologies).
A now noninvasive platform for digitizing and analyzing electrophysiology (EP) signals offers healthcare providers higher diagnostic value.
The BioSig Technologies (Austin, TX, USA) PURE EP is a cardiac signal acquisition and display system engineered to assist electrophysiologists during electrocardiographic (ECG) and intra-cardiac procedures in order to diagnose and treat patients with abnormal heart rates and rhythms. By minimize noise and artifacts while acquiring high-fidelity cardiac signals, an EP exam's diagnostic value is increased, providing a clearer picture for interpretation and planning of subsequent catheter ablation treatments.
The proprietary hardware and software are designed to effectively eliminate noise, artifact, and baseline wander in real-time, exposing high-frequency micro-components in midst of large physiologic signals; fractionated atrial and ventricular electrograms; and high-frequency, low-amplitude signals such as the Purkinje potentials. Multiple review windows and filtering algorithms allow differential diagnoses during the cardiac ablation itself, reducing procedure length compared to current technology, which requires the clinician to step out of the control room and review ECG signals and apply filters to reduce noise and artifacts.
“Our PURE EP System is the culmination of many years of scientific research and business development efforts. It is our goal to provide tangible benefits to electrophysiologists and improve the current standards of EP procedures in the clinical setting,” said Kenneth Londoner, Chairman and CEO of BioSig Technologies. “We are excited to bring the advanced platform to the U.S. market.”
Electrophysiology comprises investigation of the electrical response characteristics of nerve and muscle. In the narrower sense, an EP study is a test performed to assess the heart's electrical system or activity and is used to diagnose abnormal heartbeats or arrhythmia. The test is performed by inserting catheters and wire electrodes, which measure electrical activity. The study is performed in an EP laboratory, usually under fluoroscopic guidance.
Related Links:
BioSig Technologies
The BioSig Technologies (Austin, TX, USA) PURE EP is a cardiac signal acquisition and display system engineered to assist electrophysiologists during electrocardiographic (ECG) and intra-cardiac procedures in order to diagnose and treat patients with abnormal heart rates and rhythms. By minimize noise and artifacts while acquiring high-fidelity cardiac signals, an EP exam's diagnostic value is increased, providing a clearer picture for interpretation and planning of subsequent catheter ablation treatments.
The proprietary hardware and software are designed to effectively eliminate noise, artifact, and baseline wander in real-time, exposing high-frequency micro-components in midst of large physiologic signals; fractionated atrial and ventricular electrograms; and high-frequency, low-amplitude signals such as the Purkinje potentials. Multiple review windows and filtering algorithms allow differential diagnoses during the cardiac ablation itself, reducing procedure length compared to current technology, which requires the clinician to step out of the control room and review ECG signals and apply filters to reduce noise and artifacts.
“Our PURE EP System is the culmination of many years of scientific research and business development efforts. It is our goal to provide tangible benefits to electrophysiologists and improve the current standards of EP procedures in the clinical setting,” said Kenneth Londoner, Chairman and CEO of BioSig Technologies. “We are excited to bring the advanced platform to the U.S. market.”
Electrophysiology comprises investigation of the electrical response characteristics of nerve and muscle. In the narrower sense, an EP study is a test performed to assess the heart's electrical system or activity and is used to diagnose abnormal heartbeats or arrhythmia. The test is performed by inserting catheters and wire electrodes, which measure electrical activity. The study is performed in an EP laboratory, usually under fluoroscopic guidance.
Related Links:
BioSig Technologies
Latest Critical Care News
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events
- AI Diagnostic Tool Guides Rapid Diagnosis and Prediction of Sepsis
- World's First AI-Powered Sepsis Alert System Detects Sepsis in One Minute
- Smartphone Magnetometer Uses Magnetized Hydrogel to Measure Biomarkers for Disease Diagnosis
- New Technology to Revolutionize Valvular Heart Disease Care